• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌转移微环境的最新建模:我们在哪里?

State of the Art Modelling of the Breast Cancer Metastatic Microenvironment: Where Are We?

机构信息

Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, Oglesby Cancer Research Building, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M20 4GJ, UK.

出版信息

J Mammary Gland Biol Neoplasia. 2024 Jul 16;29(1):14. doi: 10.1007/s10911-024-09567-z.

DOI:10.1007/s10911-024-09567-z
PMID:39012440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11252219/
Abstract

Metastatic spread of tumour cells to tissues and organs around the body is the most frequent cause of death from breast cancer. This has been modelled mainly using mouse models such as syngeneic mammary cancer or human in mouse xenograft models. These have limitations for modelling human disease progression and cannot easily be used for investigation of drug resistance and novel therapy screening. To complement these approaches, advances are being made in ex vivo and 3D in vitro models, which are becoming progressively better at reliably replicating the tumour microenvironment and will in the future facilitate drug development and screening. These approaches include microfluidics, organ-on-a-chip and use of advanced biomaterials. The relevant tissues to be modelled include those that are frequent and clinically important sites of metastasis such as bone, lung, brain, liver for invasive ductal carcinomas and a distinct set of common metastatic sites for lobular breast cancer. These sites all have challenges to model due to their unique cellular compositions, structure and complexity. The models, particularly in vivo, provide key information on the intricate interactions between cancer cells and the native tissue, and will guide us in producing specific therapies that are helpful in different context of metastasis.

摘要

肿瘤细胞转移到身体周围的组织和器官是乳腺癌死亡的最常见原因。这主要是通过使用同源乳腺癌或人源异种移植模型等小鼠模型来建模的。这些模型对于模拟人类疾病进展有局限性,并且不容易用于研究耐药性和新型治疗方法的筛选。为了补充这些方法,正在开发离体和 3D 体外模型,这些模型在可靠复制肿瘤微环境方面正变得越来越好,并且将来将有助于药物开发和筛选。这些方法包括微流控、器官芯片和先进生物材料的使用。需要建模的相关组织包括那些经常发生且具有临床重要性的转移部位,例如骨、肺、脑、肝,用于浸润性导管癌,以及一组特定的常见转移性部位用于乳腺小叶癌。这些部位由于其独特的细胞组成、结构和复杂性,都具有建模的挑战性。这些模型,特别是体内模型,提供了关于癌细胞与原生组织之间复杂相互作用的关键信息,并将指导我们生产有助于不同转移背景的特定治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/11252219/35f33420baf3/10911_2024_9567_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/11252219/2e8dce670b6e/10911_2024_9567_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/11252219/35f33420baf3/10911_2024_9567_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/11252219/2e8dce670b6e/10911_2024_9567_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/11252219/35f33420baf3/10911_2024_9567_Fig2_HTML.jpg

相似文献

1
State of the Art Modelling of the Breast Cancer Metastatic Microenvironment: Where Are We?乳腺癌转移微环境的最新建模:我们在哪里?
J Mammary Gland Biol Neoplasia. 2024 Jul 16;29(1):14. doi: 10.1007/s10911-024-09567-z.
2
Clinically relevant metastatic breast cancer models to study chemosensitivity.用于研究化疗敏感性的临床相关转移性乳腺癌模型。
Methods Mol Med. 2005;111:285-95. doi: 10.1385/1-59259-889-7:285.
3
Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.使用人骨盘和乳腺癌患者来源异种移植物建立具有临床相关性的体内转移模型。
Breast Cancer Res. 2019 Nov 29;21(1):130. doi: 10.1186/s13058-019-1220-2.
4
A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.开发晚期或早期自发转移临床前模型以研究抗血管生成药物、节拍化疗和肿瘤微环境的十年经验。
Cancer J. 2015 Jul-Aug;21(4):274-83. doi: 10.1097/PPO.0000000000000134.
5
Mechanisms of Organ-Specific Metastasis of Breast Cancer.乳腺癌器官特异性转移的机制。
Cold Spring Harb Perspect Med. 2023 Nov 1;13(11):a041326. doi: 10.1101/cshperspect.a041326.
6
Biomimetic strategies to recapitulate organ specific microenvironments for studying breast cancer metastasis.用于重现器官特异性微环境以研究乳腺癌转移的仿生策略。
Int J Cancer. 2017 Sep 15;141(6):1091-1109. doi: 10.1002/ijc.30748. Epub 2017 May 10.
7
On-chip determination of tissue-specific metastatic potential of breast cancer cells.芯片上测定乳腺癌细胞的组织特异性转移潜能
Biotechnol Bioeng. 2021 Oct;118(10):3799-3810. doi: 10.1002/bit.27855. Epub 2021 Jun 21.
8
Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model.肿瘤标志物表达和微环境结构的瘤间转移异质性在临床前癌症模型中的研究。
Int J Mol Sci. 2021 Jun 13;22(12):6336. doi: 10.3390/ijms22126336.
9
Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.生物发光人类乳腺癌细胞系,可在免疫缺陷小鼠体内快速、灵敏地检测乳腺肿瘤及多处转移灶。
Breast Cancer Res. 2005;7(4):R444-54. doi: 10.1186/bcr1026. Epub 2005 Apr 8.
10
Separation of breast cancer and organ microenvironment transcriptomes in metastases.转移灶中乳腺癌与器官微环境转录组的分离。
Breast Cancer Res. 2019 Mar 6;21(1):36. doi: 10.1186/s13058-019-1123-2.

引用本文的文献

1
Buenos Aires Breast Cancer Symposium (BA-BCS 2024) A Second Successful "Trial" for Bringing Together both World Hemispheres To Debate the Future of Translational Breast Cancer Research.布宜诺斯艾利斯乳腺癌研讨会(2024年布宜诺斯艾利斯乳腺癌研讨会):汇聚两个半球共同探讨转化性乳腺癌研究未来的又一次成功“试验”。
J Mammary Gland Biol Neoplasia. 2025 Mar 15;30(1):5. doi: 10.1007/s10911-025-09577-5.
2
Methods and Models in Mammary Gland Biology and Breast Cancer Research.乳腺生物学与乳腺癌研究中的方法与模型
J Mammary Gland Biol Neoplasia. 2025 Mar 8;30(1):4. doi: 10.1007/s10911-025-09579-3.

本文引用的文献

1
Experimental models for cancer brain metastasis.癌症脑转移的实验模型
Cancer Pathog Ther. 2023 Oct 29;2(1):15-23. doi: 10.1016/j.cpt.2023.10.005. eCollection 2024 Jan.
2
Application of a 3D hydrogel-based model to replace use of animals for passaging patient-derived xenografts.应用基于3D水凝胶的模型替代使用动物传代患者来源的异种移植物。
In Vitro Model. 2023;2(3-4):99-111. doi: 10.1007/s44164-023-00048-x. Epub 2023 May 9.
3
miR-224-5p acts as a tumour suppressor and reverses the resistance to BRAF inhibitor in melanoma through directly targeting PAK4 to block the MAPK pathway.
miR-224-5p 通过直接靶向 PAK4 阻断 MAPK 通路,作为肿瘤抑制因子发挥作用,并逆转黑色素瘤对 BRAF 抑制剂的耐药性。
Pathol Res Pract. 2023 Sep;249:154772. doi: 10.1016/j.prp.2023.154772. Epub 2023 Aug 18.
4
A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs.一种合成转移龛揭示抗肿瘤中性粒细胞在肺部驱动乳腺癌转移休眠
Nat Commun. 2023 Aug 8;14(1):4790. doi: 10.1038/s41467-023-40478-5.
5
Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer.骨基质矿化抑制乳腺癌中整合素介导的机械信号转导和转移进展。
Nat Biomed Eng. 2023 Nov;7(11):1455-1472. doi: 10.1038/s41551-023-01077-3. Epub 2023 Aug 7.
6
Breast cancer brain metastasis: from etiology to state-of-the-art modeling.乳腺癌脑转移:从病因到前沿建模
J Biol Eng. 2023 Jun 29;17(1):41. doi: 10.1186/s13036-023-00352-w.
7
Recent Advancement in Breast Cancer Research: Insights from Model Organisms-Mouse Models to Zebrafish.乳腺癌研究的最新进展:从模式生物——小鼠模型到斑马鱼的见解
Cancers (Basel). 2023 May 29;15(11):2961. doi: 10.3390/cancers15112961.
8
Development of glioblastoma organoids and their applications in personalized therapy.胶质母细胞瘤类器官的发展及其在个性化治疗中的应用。
Cancer Biol Med. 2023 Jun 5;20(5):353-68. doi: 10.20892/j.issn.2095-3941.2023.0061.
9
A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma.一种具有成骨肉瘤活性的双功能 PARP-HDAC 抑制剂。
Clin Cancer Res. 2023 Sep 1;29(17):3541-3553. doi: 10.1158/1078-0432.CCR-22-3897.
10
Spatially patterned 3D model mimics key features of cancer metastasis to bone.空间模式化 3D 模型模拟癌症转移到骨骼的关键特征。
Biomaterials. 2023 Aug;299:122163. doi: 10.1016/j.biomaterials.2023.122163. Epub 2023 May 18.